New technologies and adaptations of existing technologies can improve platform processes.
Denis Boyle, PhD
Advertisement
Denis Boyle, PhD, is an associate research fellow at Pfizer BioTherapeutics Research and Development
Articles by Denis Boyle, PhD
Advertisement
Latest Updated Articles
Advances in Monoclonal Antibody PurificationPublished: March 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
